Promotion_M_Hesse_upload.pdf - Ernst-Moritz-Arndt-Universität ...

[27] CRAWLEY, E. ; KAY, R. ; SILLIBOURNE, J. ; PATEL, P. ; HUTCHINSON, I. ; WOO, P.:
Polymorphic haplotypes of the interleukin-10 5’ flanking region determine variable
interleukin- 10 transkription and are associated with particular phenotypes of
juvenile rheumatoid arthritis. In: Arthritis & Rheumatism 42 (1999), S. 1101–1108
[28] CUNHA, F.Q. ; MONCADA, S. ; LIEW, F.Y.: Interleukin-10 (IL-10) inhibits the induction
of nitric oxide synthase by interferon-gamma in murine macrophages. In:
Biochem Biophys Res Commun 182 (1992), S. 1155–1159
[29] D’ALFONSO, S. ; RAMPI, M. ; ROLANDO, V. ; GIORDANO, M. ; MOMIGLIANO-
RICHIARDI, P.: New polymorphisms in the IL-10 promotor region. In: Genes Immun
1 (2000), S. 231–233
[30] DE WAAL MALEFYT, R. ; ABRAMS, J. ; BENNET, B. ; FIGDOR, C.G. ; DE VRIES, J.E.:
IL-10 inhibits cytokine synthesis by human monocytes: An autoregulatory role of
IL- 10 produced by monocytes. In: J Exp Med 174 (1991), S. 1209–1220
[31] DE WAAL MALEFYT, R. ; DE VRIES, J.E.: Interleukin-10, ed. B.Aggarwal, J. Gutterman,
pp. 19-42. In: Cambridge MA: Blackwell Sci. (1996)
[32] DEUTSCHE SEPSIS GESELLSCHAFT: Prävalenzstudie der deutschen Sepsis Gesellschaft.
In: http://www.sepsis-gesellschaft.de
[33] DHAINAUT, J.F. ; ANTONELLI, M. ; WRIGHT, P. ; DESACHY, A. ; REIGNIER, J. ;
LAVOUE, S. ; CHARPENTIER, J. ; BELGER, M. ; COBAS-MEYER, M. ; MAIER, C.
; MIGNINI, M.A. ; JANES, J.: Extended drotrecogin alfa (activated) treatment in
patients with prolonged septic shock. In: Crit Care 13 (2009), Nr. 3, S. 1185–1195
[34] DICKENSHEETS, H.L. ; FREEMAN, S.L. ; SMITH, M.F. ; DONNELLY, R.P.: Interleukin-
10 upregulates tumor necrosis factor recepor type-II (p75) gene expression in
endotoxin-stimulated human monocytes. In: Blood 90 (1997), S. 4162–4171
[35] DING, L. ; SHEVACH, E.M.: IL-10 inhibits mitogen-induced T-cell proliferation by selectively
inhibiting macrophage costimulatory function. In: J Immunol 148 (1992),
S. 3133–3139
92